Category Archives: Pricing and Value

The Supremes and Generics

Posted on June 28, 2006 by Mark Senak

You have to admire Washington.  It is the only city in the United States where, when you don’t do anything, you make news.  At least if your name is Supreme Court. Monday the Associated Press noted that the Supremes have … Continue reading →

Posted in Generic Drugs, Pricing and Value | Comments Off on The Supremes and Generics

Generics and Pricing, Part II – A Drug, A Price and a Senator

Posted on June 26, 2006 by Mark Senak

Recently Merck announced a lowering of the price of Zocor (simvastatin) in a move that presumably will put their brand name drug in a competitive position vis a vis an upcoming generic product, just approved by the FDA.  This brought … Continue reading →

Posted in Marketing, Pricing and Value | 1 Comment

Memorial Day and Anniversaries

Posted on June 2, 2006 by Mark Senak

Well, this week is bringing up a lot of memories for me.  Today I’m going to share some of them.  I already did this once, in a memoir called A Fragile Circle.  But a number of years have passed since … Continue reading →

Posted in Pricing and Value | Comments Off on Memorial Day and Anniversaries

Clouds on the Horizon, Part III

Posted on May 18, 2006 by Mark Senak

Back on April 7, in the posting Clouds on the Horizon, Part I, I wrote about Medicare Part D and the impending donut hole. For those of you who don’t remember, or are new to the blog, the donut hole … Continue reading →

Posted in Pharma Industry Image, Pricing and Value | Comments Off on Clouds on the Horizon, Part III

More on Generics, the Pipeline and Communications

Posted on May 3, 2006 by Mark Senak

There has been a lot of news about generics lately. There are approximately 75 brand name drugs scheduled to go off-patent over the course of the next two years.  Last week, the highly lucrative statins saw the first generic among … Continue reading →

Posted in Pharma Industry Image, Pricing and Value | 3 Comments